Allworth Financial’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3
| Closed | -$12 | – | 5266 |
|
|
2025
Q3 | $12 | Hold |
3
| – | – | ﹤0.01% | 4860 |
|
|
2025
Q2 | $9 | Hold |
3
| – | – | ﹤0.01% | 4552 |
|
|
2025
Q1 | $12 | Hold |
3
| – | – | ﹤0.01% | 4019 |
|
|
2024
Q4 | $8 | Hold |
3
| – | – | ﹤0.01% | 3913 |
|
|
2024
Q3 | $10 | Hold |
3
| – | – | ﹤0.01% | 3715 |
|
|
2024
Q2 | $21 | Hold |
3
| – | – | ﹤0.01% | 3645 |
|
|
2024
Q1 | $11 | Hold |
3
| – | – | ﹤0.01% | 3566 |
|
|
2023
Q4 | $12 | Hold |
3
| – | – | ﹤0.01% | 3410 |
|
|
2023
Q3 | $51 | Hold |
3
| – | – | ﹤0.01% | 3371 |
|
|
2023
Q2 | $70 | Hold |
3
| – | – | ﹤0.01% | 3185 |
|
|
2023
Q1 | $64 | Hold |
3
| – | – | ﹤0.01% | 3117 |
|
|
2022
Q4 | $73 | Hold |
3
| – | – | ﹤0.01% | 2938 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 3081 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 2777 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 2365 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 2105 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1966 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1656 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1612 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1436 |
|
|
2020
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1125 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1355 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1319 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1106 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1012 |
|
|
2019
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 904 |
|
|
2019
Q1 | $1K | Buy |
+3
| New | +$454 | ﹤0.01% | 922 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 734 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 736 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 673 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 659 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 656 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 639 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 630 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 622 |
|
Other funds holding SNOA
DS
MCWS
GRP
TRCT
Allworth Financial's SNOA Position: Q4 2025 in Review
Allworth Financial sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2025, closing a stake of 3 shares — an estimated $12 sold.
Allworth Financial first reported a position in SNOA in Q1 2019 and held it in 27 quarters. The position peaked at $1K in Q3 2020. 16 funds tracked by Wall St. Rank hold SNOA as of Q4 2025.
- Allworth Financial reported no remaining Sonoma Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Allworth Financial sold 3 Sonoma Pharmaceuticals shares in Q4 2025, an estimated $12.
- Allworth Financial first reported a position in Sonoma Pharmaceuticals in Q1 2019 and held it in 27 quarters.
- Allworth Financial's Sonoma Pharmaceuticals position peaked at $1K in Q3 2020.
- 16 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2025.
Based on Allworth Financial's 13F filing for Q4 2025, filed 5 Feb 2026.